(MedPage Today) — Cognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the GRADE clinical trial showed.
Cognitive performance at 4.1 years of follow-up was similar in participants…
Source link : https://www.medpagetoday.com/neurology/dementia/115661
Author :
Publish date : 2025-05-19 21:31:00
Copyright for syndicated content belongs to the linked Source.
